|
1
|
Villegas VM, Hess DJ, Wildner A, Gold AS
and Murray TG: Retinoblastoma. Curr Opin Ophthalmol. 24:581–588.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society: Learn about
cancer. Retinoblastoma. https://www.cancer.org/cancer/retinoblastoma.html
|
|
3
|
Hernando E, Nahlé Z, Juan G,
Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald
W, Benezra R, et al: Rb inactivation promotes genomic instability
by uncoupling cell cycle progression from mitotic control. Nature.
430:797–802. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dimaras H, Khetan V, Halliday W, Orlic M,
Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC Jr, Squire
JA and Gallie BL: Loss of RB1 induces non-proliferative retinoma:
Increasing genomic instability correlates with progression to
retinoblastoma. Hum Mol Genet. 17:1363–1372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manning AL, Longworth MS and Dyson NJ:
Loss of pRB causes centromere dysfunction and chromosomal
instability. Genes Dev. 24:1364–1376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amato A, Lentini L, Schillaci T, Iovino F
and Di Leonardo A: RNAi mediated acute depletion of retinoblastoma
protein (pRb) promotes aneuploidy in human primary cells via
micronuclei formation. BMC Cell Biol. 10:792009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iovino F, Lentini L, Amato A and Di
Leonardo A: RB acute loss induces centrosome amplification and
aneuploidy in murine primary fibroblasts. Mol Cancer. 5:382006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin P and O'Brien JM: Frontiers in the
management of retinoblastoma. Am J Ophthalmol. 148:192–198. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dalgard CL, Gonzalez M, deNiro JE and
O'Brien JM: Differential microRNA-34a expression and tumor
suppressor function in retinoblastoma cells. Invest Ophthalmol Vis
Sci. 50:4542–4551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adriaenssens E, Dumont L, Lottin S, Bolle
D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J and Curgy
JJ: H19 overexpression in breast adenocarcinoma stromal cells is
associated with tumor values and steroid receptor status but
independent of p53 and Ki-67 expression. Am J Pathol.
153:1597–1607. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cooper MJ, Fischer M, Komitowski D,
Shevelev A, Schulze E, Ariel I, Tykocinski ML, Miron S, Ilan J, de
Groot N and Hochberg A: Developmentally imprinted genes as markers
for bladder tumor progression. J Urol. 155:2120–2127. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lottin S, Adriaenssens E, Dupressoir T,
Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ:
Overexpression of an ectopic H19 gene enhances the tumorigenic
properties of breast cancer cells. Carcinogenesis. 23:1885–1895.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Biran H, Ariel I, de Groot N, Shani A and
Hochberg A: Human imprinted genes as oncodevelopmental markers.
Tumour Biol. 15:123–134. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hibi K, Nakamura H, Hirai A, Fujikake Y,
Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in
esophageal cancer. Cancer Res. 56:480–482. 1996.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Motoyama K, Inoue H, Nakamura Y, Uetake H,
Sugihara K and Mori M: Clinical significance of high mobility group
A2 in human gastric cancer and its relationship to let-7 microRNA
family. Clin Cancer Res. 14:2334–2340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mattick JS and Gagen MJ: The evolution of
controlled multitasked gene networks: The role of introns and other
noncoding RNAs in the development of complex organisms. Mol Biol
Evol. 18:1611–1630. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gibb EA, Vucic EA, Enfield KS, Stewart GL,
Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S,
Brown CJ and Lam WL: Human cancer long non-coding RNA
transcriptomes. PLoS One. 6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Polager S and Ginsberg D: E2F-at the
crossroads of life and death. Trends Cell Biol. 18:528–535. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao J, Sun BK, Erwin JA, Song JJ and Lee
JT: Polycomb proteins targeted by a short repeat RNA to the mouse X
chromosome. Science. 322:750–756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amaral PP, Neyt C, Wilkins SJ,
Askarian-Amiri ME, Sunkin SM, Perkins AC and Mattick JS: Complex
architecture and regulated expression of the SOX2ot locus during
vertebrate development. RNA. 15:2013–2027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feldstein O, Nizri T, Doniger T, Jacob J,
Rechavi G and Ginsberg D: The long non-coding RNA ERIC is regulated
by E2F and modulates the cellular response to DNA damage. Mol
Cancer. 12:1312013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long noncoding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
MiRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wan X, Ding X, Chen S, Song H, Jiang H,
Fang Y, Li P and Guo J: The functional sites of miRNAs and lncRNAs
in gastric carcinogenesis. Tumor Biol. 36:521–532. 2015. View Article : Google Scholar
|
